Target intelligence / Profile preview

RGPD4 divergent transcript (RGPD4-DT)

Target: RGPD4-DT
Molecular classification: long non-coding RNA (lncRNA)

Overview

RGPD4 divergent transcript (RGPD4-DT, also known as RGPD4-AS1 or RGPD4 antisense RNA 1) is a long non-coding RNA gene located head-to-head (divergently) relative to the RGPD4 protein-coding gene. It is annotated in genomic resources such as NCBI, Ensembl, BioGPS, and DECIPHER as a non-protein-coding, antisense transcript. As of current evidence, there is no published characterization of its molecular function, biological pathway involvement, disease association, or pharmacological targeting. It should not be conflated with the protein-coding RGPD4 gene, which is implicated in a small number of disease-related studies[4][6].

Other names: RGPD4-AS1RGPD4 antisense RNA 1 (head to head)RGPD4-DT

Beyond the preview

Go deeper on RGPD4 divergent transcript (RGPD4-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RGPD4 divergent transcript (RGPD4-DT).

Explore the full profile